Microbiota fermentation characteristics of acylated starches and regulation mechanism of short-chain fatty acids on hepatic steatosis

2021 ◽  
Author(s):  
Mei Li ◽  
Jing Wang ◽  
Fenfen Wang ◽  
Padraig Strappe ◽  
Wenting Liu ◽  
...  

Starches acylated with specific short-chain fatty acids (SCFAs) have the potential to provide specificity in SCFA delivery. It is well documented that SCFAs are involved in lipid metabolism, but the...

2020 ◽  
Vol 21 (17) ◽  
pp. 6356 ◽  
Author(s):  
Jin He ◽  
Peiwen Zhang ◽  
Linyuan Shen ◽  
Lili Niu ◽  
Ya Tan ◽  
...  

Short-chain fatty acids (SCFAs), particularly acetate, propionate and butyrate, are mainly produced by anaerobic fermentation of gut microbes. SCFAs play an important role in regulating energy metabolism and energy supply, as well as maintaining the homeostasis of the intestinal environment. In recent years, many studies have shown that SCFAs demonstrate physiologically beneficial effects, and the signalling pathways related to SCFA production, absorption, metabolism, and intestinal effects have been discovered. Two major signalling pathways concerning SCFAs, G-protein-coupled receptors (GPRCs) and histone deacetylases (HDACs), are well recognized. In this review, we summarize the recent advances concerning the biological properties of SCFAs and the signalling pathways in inflammation and glucose and lipid metabolism.


2019 ◽  
Vol 20 (19) ◽  
pp. 4738 ◽  
Author(s):  
Yiqiong Yuan ◽  
Qibing Liu ◽  
Fuqiang Zhao ◽  
Jun Cao ◽  
Xuanri Shen ◽  
...  

Holothuria leucospilota polysaccharides (HLP) are expected to become potential resources for the treatment of hyperlipidemia because of their various bioactivities. In the study, the treatment of HLP on improving hyperlipidemia in rats was explored. Oral administration of HLP at 100 or 200 mg/kg body weight effectively alleviated serum lipid levels and liver histological abnormalities in high-fat-diet rats. HLP regulated abnormal mRNA, lipogenesis-related hormones and inflammatory cytokines (tumor necrosis factor-α, interleukin-6 and interleukin-12) levels. HLP improved the ability of gut microbiota to produce short-chain fatty acids (SCFAs). SCFAs have been found to ameliorate liver lesions. Therefore, HLP alleviated hyperlipidemia by improving the levels of SCFAs to regulate lipid metabolism. These results indicated that HLP could be used as beneficial polysaccharides to alleviate hyperlipidemia.


2018 ◽  
Vol 48 ◽  
pp. 266-274 ◽  
Author(s):  
Ângela Giovana Batista ◽  
Juliana Kelly da Silva-Maia ◽  
Monique Culturato P. Mendonça ◽  
Edilene Siqueira Soares ◽  
Glaucia Carielo Lima ◽  
...  

Adipocyte ◽  
2016 ◽  
Vol 5 (4) ◽  
pp. 359-368 ◽  
Author(s):  
Emilia Heimann ◽  
Margareta Nyman ◽  
Ann-Ki Pålbrink ◽  
Karin Lindkvist-Petersson ◽  
Eva Degerman

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 892
Author(s):  
Shrushti Shah ◽  
Tiffany Fillier ◽  
Thu Huong Pham ◽  
Raymond Thomas ◽  
Sukhinder Kaur Cheema

Short-chain fatty acids (SCFAs) are microbial metabolites, mainly generated by the action of gut microbiota on dietary fibers. Acetate, propionate, and butyrate are the three main SCFAs produced typically in a 60:20:20 molar ratio in the colon. Acetate, propionate, and butyrate, when given individually as supplements, have shown a protective role in obesity and hyperglycemia; however, the sex-specific effects of a mixture of SCFAs, when given in 60:20:20 ratio, on the regulation of lipid metabolism and lipid profile are not known. Male and female Long–Evans rats were given a mixture of SCFAs (acetate, propionate, and butyrate; molar ratio 60:20:20) each day for seven days intraperitoneally; plasma and hepatic lipids, gene expression, and lipidomics profile were analyzed. SCFAs significantly decreased plasma and hepatic triglycerides and cholesterol in males, whereas the fatty acyl composition of cholesteryl esters, triglycerides, and phospholipids was modulated in females. SCFAs decreased the mRNA expression of hepatic acetyl-CoA carboxylase-1 in both males and females. Our findings demonstrate for the first time that SCFAs (60:20:20) improved plasma and hepatic lipid levels and fatty acyl composition in a manner that may provide cardio-protective and anti-inflammatory effects in both sexes, via independent mechanisms.


Sign in / Sign up

Export Citation Format

Share Document